black bar

additive

Subtitle

black bar

peptides

Subtitle

black bar

epidermal_matrix

Subtitle

Matrixyl | Palmitoyl Pentapeptide-4

hexagon logo

vial

hexagon logo

Matrixyl research in skin rejuvenation at the extracellular matrix level,  wrinkle inhibitor, skin firmness, elasticity, and overall dermal texture.

$64.00

  • COLD-CHAIN LOGISTICS
  • LAB TESTED
  • ASSURED SHIPPING
  • BATCH CODING

In stock

Guaranteed Safe Checkout

visa accepted
mastercard accepted
discover credit card accepted
amex accepted
  • By purchasing any products, you acknowledge and agree that all materials are supplied solely for scientific research, laboratory experimentation, or analytical purposes.
Form
Lyophilized
Molecular Formula
See COA
Molecular Weight
See COA
CAS Number
See COA
PubChem CID
See COA
Research Data
Primary Effect Over Time
Literature
Cellular Ratio
Comparative Metric
Activity Profile
Activity Profile
Mechanism
Cellular Pathway
01
Procollagen C-Propeptide Autocrine Mimicry
02
ECM Gene Activation
03
Photoaged Skin Remodeling
Metabolic Network
Biosynthesis Map
Procollagen C-Propeptide Autocrine Mimicry
ECM Gene Activation
Photoaged Skin Remodeling
Signal Output
Response
Repair Systems
Stress
Mitochondria
Energy
MATRIXYL CENTRAL HUB
Sequence Analysis
Amino Acid Sequence
Single-letter residue map colored by physicochemical property class. Hover any residue for full name and position.
P A L K T T K S
8Residues
See COAMol. Weight
+2Net Charge
2Basic
0Acidic
■ Hydrophobic ■ Polar ■ Positively Charged ■ Negatively Charged ■ Glycine
Research Focus
Research Coverage
Product Data
Compound Identity
Product NameMatrixyl | Palmitoyl Pentapeptide-4
Functional ClassDermatics
FormLyophilized
Purity99%+
Content5mg
Count1 vial
Research UseResearch Grade
Specifications
Technical Specs
CAS NumberSee COA
Molecular WeightSee COA
Molecular FormulaSee COA
PubChem CIDSee COA
AppearanceWhite to off-white powder
Storage2-8C preferred
Formulation Reference
Anatomy of a Peptide
A reference guide to the components of a lyophilized research peptide — from the active sequence to the excipients, solvents, buffers, and stabilizers used in formulation.
Active Peptide 2 items
Synthetic Amino Acid Sequence
The primary chain of amino acids synthesized via solid-phase peptide synthesis (SPPS). Defined by sequence length and molecular weight.
Peptide Modifications
Acetylation (N-terminus), amidation (C-terminus), PEGylation, or cyclization applied to improve stability, receptor binding, or half-life.
Excipients 4 items
Mannitol
Sugar alcohol bulking agent that forms an elegant lyophilized cake, aids reconstitution, and provides structural matrix during freeze-drying.
Trehalose
Non-reducing disaccharide that stabilizes peptide secondary structure by replacing water molecules through hydrogen bonding during dehydration.
Sucrose
Disaccharide used as a lyoprotectant and tonicity agent. Forms an amorphous glassy matrix that immobilizes the peptide and prevents aggregation.
Glycine
Amino acid bulking agent used in lyophilization. Crystallizes to provide mechanical strength to the freeze-dried cake structure.
Reconstitution Solvents 4 items
Bacteriostatic Water (BAC Water)
Sterile water containing 0.9% benzyl alcohol as a preservative. Preferred for multi-dose vials — inhibits microbial growth after initial puncture.
Sterile Water for Injection
USP-grade water, pyrogen-free, without preservatives. Used for single-dose preparations or when benzyl alcohol sensitivity is a concern.
Acetic Acid Solution (0.1–1%)
Dilute acid used for peptides with poor aqueous solubility at neutral pH. Protonates basic residues to improve dissolution.
Sodium Chloride 0.9%
Isotonic saline diluent. Provides physiological osmolality (~308 mOsm/L) and can improve stability of certain charged peptides.
Buffer Systems 4 items
Phosphate Buffered Saline (PBS)
Maintains pH 7.2–7.4. Composed of sodium phosphate dibasic, potassium phosphate monobasic, NaCl, and KCl. Mimics physiological ionic strength.
Acetate Buffer
Effective pH range 3.7–5.6. Composed of acetic acid and sodium acetate. Ideal for acidic peptides and those requiring lower pH for solubility.
Citrate Buffer
Effective pH range 3.0–6.2. Offers strong buffering capacity and metal-chelating properties. Used when oxidation-sensitive residues (Met, Cys) are present.
Histidine Buffer
Effective pH range 5.5–7.0. Low ionic strength, minimal interaction with peptides. Increasingly preferred in modern biopharmaceutical formulations.
Lyoprotectants & Cryoprotectants 3 items
Trehalose / Sucrose (Lyoprotectant)
Protect peptide conformation during the drying phase of lyophilization by forming hydrogen bonds that substitute for water molecules around the peptide.
Glycerol (Cryoprotectant)
Polyol that depresses the freezing point and reduces ice crystal formation, preventing mechanical damage to peptide structure during freezing steps.
Polyethylene Glycol (PEG)
Hydrophilic polymer that provides steric stabilization, reduces aggregation, and can serve as both cryoprotectant and solubility enhancer.
Preservatives & Antimicrobials 3 items
Benzyl Alcohol (0.9%)
Aromatic alcohol preservative in bacteriostatic water. Acts as antimicrobial agent by disrupting microbial cell membranes. Standard for multi-use vials.
Methyl / Propyl Parabens
Broad-spectrum antimicrobial preservatives effective against fungi and bacteria. Used in some peptide formulations where benzyl alcohol is incompatible.
Phenol (0.5%)
Bacteriostatic preservative used in certain injectable peptide formulations. Also acts as a conformational stabilizer for some peptide structures.
Counter Ions & Salt Forms 3 items
Trifluoroacetate (TFA)
Most common counter ion from RP-HPLC purification. Forms TFA salt with basic residues (Lys, Arg, His). May affect bioassay results and cell toxicity.
Acetate
Milder alternative to TFA obtained via ion exchange. Lower cytotoxicity, preferred for cell-based research assays and in vivo studies.
Hydrochloride (HCl)
Chloride salt form, sometimes used for improved stability or specific solubility profiles. Common in pharmaceutical-grade peptide preparations.
Chelating Agents 2 items
EDTA (Disodium)
Chelates divalent metal ions (Cu²⁺, Fe²⁺, Zn²⁺) that catalyze oxidative degradation of methionine and cysteine residues in peptides.
Citric Acid
Natural chelator with moderate metal-binding capacity. Dual function as buffer component and oxidation inhibitor in peptide formulations.
Antioxidants & Stabilizers 3 items
L-Methionine
Free methionine added as a sacrificial antioxidant. Preferentially oxidizes before methionine residues within the peptide chain.
Ascorbic Acid
Water-soluble antioxidant that scavenges reactive oxygen species. Used at low concentrations to prevent oxidative peptide degradation.
Polysorbate 20 / 80
Non-ionic surfactants that prevent surface adsorption and aggregation of peptides at air-liquid and container-liquid interfaces.
Preparation Tool
Reconstitution Calculator
Enter your target working concentration to calculate the exact solvent volume needed for this vial.
mg
Recommended solvents
Bacteriostatic Water Sterile Water for Injection Acetic Acid 0.1% Sodium Chloride 0.9%
Product Specs
Solubility Profile
WaterHighly soluble
Acidified WaterHighly soluble
DMSOHighly soluble
EthanolModerate
Lipid solventsPoor compatibility
Product Specs
Storage Specs
Lyophilized2–8°C preferred
Long-term−20°C recommended
Light SensitivityModerate
MoistureHigh sensitivity
StabilityStable when dry
ContainerSterile sealed vial
Literature
Research Citations
Catalogue Pathway
Related Systems
Use this for internal linking, adjacent products, and quick route-back buttons.
!
Important Notice
Research Use Only

AminoBox products are supplied for research, analytical, and laboratory use only. Product information is provided for educational and technical reference and does not constitute medical advice. Products are not intended to diagnose, treat, cure, or prevent any disease.

Chemical Specifications – Matrixyl® (Palmitoyl Pentapeptide-4) 100mg

Specification Details
Product Name Matrixyl®
INCI Name Palmitoyl Pentapeptide-4
Alternative Names Pal-KTTKS, Matrixyl, Micro-Collagen
Peptide Classification Synthetic Lipopeptide (Matrikine Peptide)
Content 100mg
CAS Number 214047-00-4
EC Number 606-757-9
UNII KK181SM5JG
Molecular Formula C₃₉H₇₅N₇O₁₀
Molecular Weight 802.1 g/mol
Amino Acid Sequence Lys-Thr-Thr-Lys-Ser (KTTKS)
Structure Type Palmitoylated Pentapeptide
Appearance White to Off-White Lyophilized Powder
Purity ≥95% (HPLC)
Solubility Water Soluble / Amphiphilic (enhanced skin penetration via lipophilic chain)
Source Synthetic Peptide
Grade Cosmetic Research Grade
Sterility Non-Sterile
Preservatives None
Carrier Additives None
Intended Use Cosmetic formulation & laboratory research only
Storage Conditions -20°C, protected from light and moisture

Physical Properties

Property Specification
Physical Form Lyophilized Powder
Color White to Off-White
Odor Odorless
Stability Stable under frozen storage conditions
Moisture Sensitivity Hygroscopic – keep tightly sealed
pH Compatibility Range ~4.0 – 7.0 (formulation dependent)
Peptide Content ≥95%
Heavy Metals Meets cosmetic research standards
Microbial Load Tested per batch

Packaging Information

Attribute Details
Net Content 100mg
Container Type Laboratory-grade glass jar
Container Size 2mL
Closure Type Screw-on lid
Packaging Material Borosilicate glass
Storage Condition Refrigerated or frozen (-20°C recommended)
Shelf Life 24 months unopened (proper storage conditions)
Handling Recommendation Avoid repeated exposure to moisture and air

Cosmetic Research Profile

Category Research Focus
Primary Function Collagen-support & skin matrix appearance research
Mechanism Studied Matrikine signaling (extracellular matrix communication)
Target Pathways TGF-β / ECM remodeling signaling pathways
Research Interest Dermal density, elasticity, and wrinkle appearance studies
Cosmetic Category Anti-aging peptide (signal peptide)
Peptide Family Matrikines / ECM signaling peptides
Application Areas Serums, creams, multi-peptide cosmetic systems
Research Domain Cosmetic science & skin-aging research

Scientific Summary

Attribute Summary
Classification Palmitoylated synthetic pentapeptide
INCI Designation Palmitoyl Pentapeptide-4
Common Name Matrixyl®
Core Research Interest Collagen and extracellular matrix signaling
Primary Cosmetic Focus Skin firmness and wrinkle appearance research
Key Structural Feature KTTKS peptide sequence + palmitic acid chain
Molecular Weight 802.1 g/mol
Formula C₃₉H₇₅N₇O₁₀
Notable Property Enhanced skin affinity via lipophilic palmitoyl group

Buy Palmitoyl Pentapeptide-4 | Matrixyl

Mechanism of Action

Matrixyl is designed to replicate fragments of type I collagen degradation products, which are naturally generated when the skin undergoes structural remodeling. These fragments act as biological “messengers,” signaling dermal fibroblasts to increase synthesis of key structural proteins.

The primary signaling cascade influenced by Palmitoyl Pentapeptide-4 is associated with:

  • Collagen Type I production
  • Collagen Type III support
  • Fibronectin synthesis
  • Glycosaminoglycan (GAG) regulation
  • Extracellular matrix remodeling

Through these pathways, Matrixyl helps stimulate the skin’s natural repair mechanisms, encouraging a more youthful structural environment within the dermis. (mdpi.com)

As skin ages, fibroblast activity declines, leading to reduced collagen density, weakened dermal structure, and visible formation of fine lines and wrinkles. Matrixyl is designed to counteract these processes by restoring biological signaling that supports extracellular matrix renewal.


Advanced Biomimetic Peptide Engineering

Matrixyl belongs to the matrikine family of peptides — a class of biomimetic compounds that replicate endogenous signaling fragments involved in tissue repair.

Its chemical structure:

Palmitoyl-Lys-Thr-Thr-Lys-Ser-OH

has been optimized with a palmitoyl fatty acid chain to enhance lipid solubility, improve skin affinity, and increase compatibility with topical delivery systems. This modification allows better integration into the skin’s lipid matrix and improves overall formulation performance. (incidecoder.com)

Matrixyl is frequently incorporated into high-end serums, anti-aging creams, eye treatments, and multi-peptide complexes designed for comprehensive dermal rejuvenation.


Cosmetic Research Applications

Matrixyl is extensively studied in cosmetic formulation science for its role in:

  • Fine line and wrinkle appearance reduction
  • Skin firmness and elasticity support
  • Dermal density improvement
  • Photoaging correction systems
  • Texture refinement and smoothing
  • Collagen-supportive anti-aging systems
  • Extracellular matrix regeneration support
  • Advanced peptide-based skincare formulations
  • Multi-pathway anti-aging protocols

Clinical and formulation research has shown that consistent topical application of Palmitoyl Pentapeptide-4 may contribute to visible improvements in wrinkle depth, skin smoothness, and overall dermal resilience over time. (specialchem.com)


Synergistic Formulation Potential

Matrixyl is commonly combined with other advanced cosmetic actives to create multi-dimensional anti-aging systems that address hydration, signaling, barrier support, and pigmentation simultaneously.

Frequently paired ingredients include:

  • Hyaluronic Acid
  • SNAP-8 (Acetyl Octapeptide-3)
  • SYN-COLL® (Palmitoyl Tripeptide-5)
  • SYN-AKE® (Tripeptide-3)
  • Copper peptides (GHK-Cu)
  • Niacinamide
  • Ceramides
  • Retinoids
  • Growth factors
  • Antioxidant complexes (Vitamin C, E systems)

These combinations are often used in high-performance cosmeceutical formulations designed to support both immediate cosmetic improvement and long-term dermal restructuring.


Important Disclaimer

This product is supplied strictly for cosmetic, laboratory, and research purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption or injectable use. Cosmetic additive intended exclusively for formulation and research applications.

Scientific References – Melanostatine™-5 (Nonapeptide-1)

Title Focus Link
Discovery and Structure-Function Analysis of α-Melanocyte-Stimulating Hormone Antagonists Foundational identification of α-MSH antagonist peptides including Nonapeptide-1 and their role in MC1R binding and melanogenesis regulation https://pubmed.ncbi.nlm.nih.gov/7989360/
Characterization of Melanocortin Receptor Ligand Binding and Antagonist Activity Receptor-level analysis of MC1R antagonists and peptide binding affinity relevant to pigmentation control mechanisms https://pubmed.ncbi.nlm.nih.gov/9054419/
α-MSH Signaling and Regulation of Melanocyte Function in Human Skin Overview of α-MSH → MC1R signaling cascade governing melanin synthesis and pigmentation biology https://pubmed.ncbi.nlm.nih.gov/10816655/
Melanogenesis: Molecular Mechanisms and Regulation Pathways Comprehensive review of melanogenesis pathways including tyrosinase activation, MITF signaling, and pigment production control https://pubmed.ncbi.nlm.nih.gov/23539007/
MC1R Antagonists and Regulation of Skin Pigmentation in Preclinical Models Study overview of competitive MC1R inhibition and downstream reduction of melanogenic signaling activity https://pubmed.ncbi.nlm.nih.gov/15893405/
Nonapeptide-1 (Melanostatine-5) Mechanism Overview Summary of MC1R antagonism, α-MSH inhibition, and melanogenesis reduction in cosmetic research models https://ci.guide/peptides/nonapeptide-1/